| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/26/2005 | US6884436 Mixing a solution of a drug with a second solvent to precipitate the drug and seeding |
| 04/26/2005 | US6884435 A biodegradable polymer of a poly(alpha-hydroxyacid), polyhydroxybutryic acid, polycaprolactone, polyorthoester, polyanhydride or polycyanoacrylate, a cationic detergent and adsorbed polynucleotide antigen; vaccines; injections |
| 04/26/2005 | US6884434 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof |
| 04/26/2005 | US6884433 Time release agents comprising drugs such as tacrolimus in solid solutions |
| 04/26/2005 | US6884432 Scaffold for tissue regeneration |
| 04/26/2005 | US6884431 Method for treating proliferative diseases with p27 and fusions thereof |
| 04/26/2005 | US6884430 Formulation of stabilized cationic transfection agent(s) /nucleic acid particles |
| 04/26/2005 | US6884422 Freeze-dried hepatitis A attenuated live vaccine and its stabilizer |
| 04/26/2005 | US6884413 Immunosuppressants for organ transplantions by inducing apoptosis/anergy in T cells; genetic engineering; antigen presenting cells |
| 04/26/2005 | US6884411 For oral administrations; isolated from lymphoblastoids/ lymphocytes |
| 04/26/2005 | US6884408 Delivery of diphenhydramine through an inhalation route |
| 04/26/2005 | US6884372 Method for preparing microparticles using liquid-liquid extraction |
| 04/26/2005 | US6884288 A mixture comprising gum acacia, hydroxypropyl methylcellulose and propylene glycol plasticizer, forming a water solution to coat on drug tablets, food, and candy; long shelf life and low shipping costs |
| 04/26/2005 | US6884239 Ingestible device for the release of substances at distinct locations in alimentary canal |
| 04/26/2005 | US6884060 Apparatus for manufacturing encapsulated products |
| 04/26/2005 | US6883516 Preparing solution of first component in liquid component such that after volatilization of liquid by passing solution through flow passage while heating, aerosol is formed having predetermined particle size distribution of first component |
| 04/26/2005 | CA2287333C Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it |
| 04/26/2005 | CA2216810C Method for treatment of benign prostatic hypertrophy |
| 04/26/2005 | CA2211033C Solid active compound preparations |
| 04/26/2005 | CA2165830C Salmeterol xinafoate with controlled particle size |
| 04/26/2005 | CA2155520C Starch hydrolysates as sequesterers |
| 04/26/2005 | CA2152505C Method for preparing a viral aerosol |
| 04/21/2005 | WO2005036165A1 Screening method of formulating a pharmaceutical composition by using model compounds |
| 04/21/2005 | WO2005036109A2 Integrating ultraviolet exposure detection devices |
| 04/21/2005 | WO2005035779A2 Method |
| 04/21/2005 | WO2005035733A2 Modified whole cell, cell extract and omv-based vaccines |
| 04/21/2005 | WO2005035651A1 Finely particulate composite containing carbon compound encapsulated therein |
| 04/21/2005 | WO2005035606A1 Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery |
| 04/21/2005 | WO2005035574A1 IgM HIGH CONCENTRATION STABILIZED SOLUTION |
| 04/21/2005 | WO2005035477A1 Method of stabilizing compound having quinone skeleton and stabilized composition |
| 04/21/2005 | WO2005035088A2 Method for preparing small spherical by controlled phase separation |
| 04/21/2005 | WO2005034979A2 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| 04/21/2005 | WO2005034973A1 Capsulated herbal composition as auxilary medicament against diabetes mellitus type (i) and (ii) |
| 04/21/2005 | WO2005034972A2 Use of pharmaceutical compositions containing evening primrose oil for the treatment of xerostomia |
| 04/21/2005 | WO2005034969A1 Medicament on the basis of honey, preparation and use thereof |
| 04/21/2005 | WO2005034968A1 Solution for cessation of smoking and method to use |
| 04/21/2005 | WO2005034966A1 Use of xenon with hypothermia for treating neonatal asphyxia |
| 04/21/2005 | WO2005034957A1 Noncrystalline antibacterial composition containing cefditoren pivoxil |
| 04/21/2005 | WO2005034956A1 Antimycotic nail polish formulations comprising substituted 2-aminothiazoles as an active substance |
| 04/21/2005 | WO2005034954A2 Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation |
| 04/21/2005 | WO2005034948A1 Solid dosage formulation containing a factor xa inhibitor and method |
| 04/21/2005 | WO2005034945A1 Use of norphenazone and coenzyme q for curing arthrose, arthritis and osteoarthritis |
| 04/21/2005 | WO2005034944A1 Combinations of indole compounds and alkylating agents for the treatment of cancer |
| 04/21/2005 | WO2005034935A1 Use of organoarsenic or organoantimony derivatives for their anticancer properties |
| 04/21/2005 | WO2005034930A1 Pellets containing venlafaxine hydrochloride |
| 04/21/2005 | WO2005034928A1 Rapid dissolution formulation of a calcium receptor-active compound |
| 04/21/2005 | WO2005034927A2 Aerosol formulation comprising formoterol in suspension |
| 04/21/2005 | WO2005034926A2 Non-invasive system for detecting skin cancer |
| 04/21/2005 | WO2005034925A1 Lowly irritative adhesive patch |
| 04/21/2005 | WO2005034924A1 Enteric coated pellets comprising esomeprazole, hard gelatin capsule containing them, and method of preparation |
| 04/21/2005 | WO2005034923A1 Sustained-release microgranules containing gingko biloba extract and the process for manufacturing these |
| 04/21/2005 | WO2005034922A1 Compositions for conjugated estrogens and associated methods |
| 04/21/2005 | WO2005034921A1 Rapidly disintegrating formulation |
| 04/21/2005 | WO2005034920A1 A solid dosage form comprising a fibrate |
| 04/21/2005 | WO2005034919A2 Method of producing dosage units of a solid drug form containing warfarin sodium salt as active component |
| 04/21/2005 | WO2005034918A1 Pellets containing a pharmaceutical ingredient |
| 04/21/2005 | WO2005034917A2 Hydrophobic silica-based water powder |
| 04/21/2005 | WO2005034915A2 Screening method for evaluation of bilayer-drug interaction in liposomal compositions |
| 04/21/2005 | WO2005034914A1 Emulsified solution containing psysiological activation material, a method for preparing thereof, and a method for administration thereof |
| 04/21/2005 | WO2005034913A1 Novel liquid preparation composition |
| 04/21/2005 | WO2005034912A2 Ferromagnetic particles and methods |
| 04/21/2005 | WO2005034911A1 Aerosol formulations comprising formoterol fumarate dihydrate, a propellant,ethanol and optionally a steroid,where the formoterol fumarate dihydrate has a water content of 4.8-4.28% by weight |
| 04/21/2005 | WO2005034910A1 Oral liquid pharmaceutical compositions of sertraline |
| 04/21/2005 | WO2005034908A2 A solid dosage form comprising a fibrate and a statin |
| 04/21/2005 | WO2005034907A1 Skin care topical ointment |
| 04/21/2005 | WO2005034872A2 Drug-delivery vehicles based on reversed liquid crystalline phase materials |
| 04/21/2005 | WO2005034861A2 A dried biotherapeutic composition, uses, and device and methods for administration thereof |
| 04/21/2005 | WO2005034859A2 Extended release formulations of opioids and method of use thereof |
| 04/21/2005 | WO2005034854A2 Water dispersible film |
| 04/21/2005 | WO2005034852A2 Protein biomaterials and biocoacervates and methods of making and using thereof |
| 04/21/2005 | WO2005021968A3 A valve for controlling flow of a fluid |
| 04/21/2005 | WO2005020965A3 Skeletally targeted nanoparticles |
| 04/21/2005 | WO2005020956A3 Microparticles |
| 04/21/2005 | WO2005018687A3 Particle-size reduction apparatus, and use thereof |
| 04/21/2005 | WO2005011737A3 Pharmaceutical combinations and formulations with improved stability |
| 04/21/2005 | WO2005004878A3 Multi-use vessels for vitamin d formulations, preferably administeredat high dose and periodically |
| 04/21/2005 | WO2005004842A3 Formulations for coated microprojections containing non-volatile counterions |
| 04/21/2005 | WO2005002625A3 In-situ gelling drug delivery system |
| 04/21/2005 | WO2005002544A3 Stabilized particle dispersions containing nanoparticles |
| 04/21/2005 | WO2004105782A3 Drug delivery systems for tumor targeting ngr-molecules and uses thereof |
| 04/21/2005 | WO2004103341A3 Dissolvable backing layer for use with a transmucosal delivery device |
| 04/21/2005 | WO2004100866A3 Alcohol-free transdermal analgesic composition |
| 04/21/2005 | WO2004091530B1 Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom |
| 04/21/2005 | WO2004089291A3 Tumor-targeting drug-loaded particles |
| 04/21/2005 | WO2004073768A3 Occlusion resistant hydrocephalic shunt |
| 04/21/2005 | WO2004071386A3 Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use |
| 04/21/2005 | WO2004069291A3 Instrument for assisting in the remote placement of tied surgical knots and trimming of suture away from the knot and method of use |
| 04/21/2005 | WO2004060443A3 Apparatuses and methods for automatically assessing and monitoring a patient’s responsiveness |
| 04/21/2005 | WO2004060268A8 A method and article to control cellulite |
| 04/21/2005 | WO2004018066A3 Aqueous two-phase systems for particle manipulation and encapsulation within microscopic volumes |
| 04/21/2005 | WO2004014143A8 Compositions and process for delivering an additive |
| 04/21/2005 | WO2004008871A3 Device for orally absorbing a substance, use thereof as confectionery, tonic food, (phyto)therapeutic product and dental hygiene product and method for making such a device |
| 04/21/2005 | WO2003101421A8 Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof |
| 04/21/2005 | WO2003061584A3 Novel substituted benzimidazole dosage forms and method of using same |
| 04/21/2005 | WO2003056951A3 Antimicrobial body covering articles |
| 04/21/2005 | WO2002098348A3 Glp-1 formulations with protracted time action |
| 04/21/2005 | US20050085860 Transdermal/transmucosal preparations for electroporation |
| 04/21/2005 | US20050085797 Osmotic delivery system having space efficient piston |
| 04/21/2005 | US20050085796 Equine medicinal applicator |
| 04/21/2005 | US20050085791 Disinfectant, antibiotic and anesthetic containing device for injections and incisions |